42 related articles for article (PubMed ID: 10527676)
1. Autistic Siblings with Novel Mutations in Two Different Genes: Insight for Genetic Workups of Autistic Siblings and Connection to Mitochondrial Dysfunction.
Burger BJ; Rose S; Bennuri SC; Gill PS; Tippett ML; Delhey L; Melnyk S; Frye RE
Front Pediatr; 2017; 5():219. PubMed ID: 29075622
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome.
Frye RE; Rose S; Slattery J; MacFabe DF
Microb Ecol Health Dis; 2015; 26():27458. PubMed ID: 25956238
[TBL] [Abstract][Full Text] [Related]
3. Redox metabolism abnormalities in autistic children associated with mitochondrial disease.
Frye RE; Delatorre R; Taylor H; Slattery J; Melnyk S; Chowdhury N; James SJ
Transl Psychiatry; 2013 Jun; 3(6):e273. PubMed ID: 23778583
[TBL] [Abstract][Full Text] [Related]
4. Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder.
Frye RE; Melnyk S; Macfabe DF
Transl Psychiatry; 2013 Jan; 3(1):e220. PubMed ID: 23340503
[TBL] [Abstract][Full Text] [Related]
5. Essential fatty acid profiling for routine nutritional assessment unmasks adrenoleukodystrophy in an infant with isovaleric acidaemia.
Bonilla Guerrero R; Wolfe LA; Payne N; Tortorelli S; Matern D; Rinaldo P; Gavrilov D; Melan M; He M; Steinberg SJ; Raymond GV; Vockley J; Gibson KM
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S453-6. PubMed ID: 19089597
[TBL] [Abstract][Full Text] [Related]
6. Carnitine palmitoyltransferase II deficiency: successful anaplerotic diet therapy.
Roe CR; Yang BZ; Brunengraber H; Roe DS; Wallace M; Garritson BK
Neurology; 2008 Jul; 71(4):260-4. PubMed ID: 18645163
[TBL] [Abstract][Full Text] [Related]
7. Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression.
Mochel F; Charles P; Seguin F; Barritault J; Coussieu C; Perin L; Le Bouc Y; Gervais C; Carcelain G; Vassault A; Feingold J; Rabier D; Durr A
PLoS One; 2007 Jul; 2(7):e647. PubMed ID: 17653274
[TBL] [Abstract][Full Text] [Related]
8. A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening.
Ensenauer R; Vockley J; Willard JM; Huey JC; Sass JO; Edland SD; Burton BK; Berry SA; Santer R; Grünert S; Koch HG; Marquardt I; Rinaldo P; Hahn S; Matern D
Am J Hum Genet; 2004 Dec; 75(6):1136-42. PubMed ID: 15486829
[TBL] [Abstract][Full Text] [Related]
9. Analysis of organic acids after incubation with (16-2H3)palmitic acid in fibroblasts from patients with mitochondrial beta-oxidation defects.
Osorio JH; Lluch M; Ribes A
J Inherit Metab Dis; 2003; 26(8):795-803. PubMed ID: 14739684
[TBL] [Abstract][Full Text] [Related]
10. Respiratory complex II defect in siblings associated with a symptomatic secondary block in fatty acid oxidation.
Gargus JJ; Boyle K; Bocian M; Roe DS; Vianey-Saban C; Roe CR
J Inherit Metab Dis; 2003; 26(7):659-70. PubMed ID: 14707514
[TBL] [Abstract][Full Text] [Related]
11. Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride.
Roe CR; Sweetman L; Roe DS; David F; Brunengraber H
J Clin Invest; 2002 Jul; 110(2):259-69. PubMed ID: 12122118
[TBL] [Abstract][Full Text] [Related]
12. Applications of mass spectrometry in the study of inborn errors of metabolism.
Clayton PT
J Inherit Metab Dis; 2001 Apr; 24(2):139-50. PubMed ID: 11405336
[TBL] [Abstract][Full Text] [Related]
13. Carnitine palmitoyltransferase I deficiency in neonate identified by dried blood spot free carnitine and acylcarnitine profile.
Sim KG; Wiley V; Carpenter K; Wilcken B
J Inherit Metab Dis; 2001 Feb; 24(1):51-9. PubMed ID: 11286383
[TBL] [Abstract][Full Text] [Related]
14. Recent developments in the investigation of inherited metabolic disorders using cultured human cells.
Roe CR; Roe DS
Mol Genet Metab; 1999 Oct; 68(2):243-57. PubMed ID: 10527676
[TBL] [Abstract][Full Text] [Related]
15. Analysis of mitochondrial fatty acid oxidation intermediates by tandem mass spectrometry from intact mitochondria prepared from homogenates of cultured fibroblasts, skeletal muscle cells, and fresh muscle.
Tyni T; Pourfarzam M; Turnbull DM
Pediatr Res; 2002 Jul; 52(1):64-70. PubMed ID: 12084849
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
[TBL] [Abstract][Full Text] [Related]
17. Analysis of carnitine esters by radio-high performance liquid chromatography in cultured skin fibroblasts from patients with mitochondrial fatty acid oxidation disorders.
Schmidt-Sommerfeld E; Bobrowski PJ; Penn D; Rhead WJ; Wanders RJ; Bennett MJ
Pediatr Res; 1998 Aug; 44(2):210-4. PubMed ID: 9702916
[TBL] [Abstract][Full Text] [Related]
18. Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways.
Vockley J; Rinaldo P; Bennett MJ; Matern D; Vladutiu GD
Mol Genet Metab; 2000; 71(1-2):10-8. PubMed ID: 11001791
[TBL] [Abstract][Full Text] [Related]
19. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
Stanley CA
Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
